These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 7653728)

  • 1. [Replacement hormonal therapy in correction of metabolic-trophic changes in ovarian failure syndrome].
    Kuznetsov SIu
    Akush Ginekol (Mosk); 1995; (3):38-41. PubMed ID: 7653728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiological versus standard sex steroid replacement in young women with premature ovarian failure: effects on bone mass acquisition and turnover.
    Crofton PM; Evans N; Bath LE; Warner P; Whitehead TJ; Critchley HO; Kelnar CJ; Wallace WH
    Clin Endocrinol (Oxf); 2010 Dec; 73(6):707-14. PubMed ID: 20738314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The use of the triphasic contraceptive preparation trisiston for therapeutic purposes].
    Vasilev D; Katsarova M; Dikov I; Rachev E
    Akush Ginekol (Sofiia); 1990; 29(1):79-83. PubMed ID: 2372104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of hormone replacement therapy on lipoprotein(a) and lipid levels in postmenopausal women. Influence of various progestogens and duration of therapy.
    Kim CJ; Min YK; Ryu WS; Kwak JW; Ryoo UH
    Arch Intern Med; 1996 Aug 12-26; 156(15):1693-700. PubMed ID: 8694668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical study comparing the effects of sequential hormone replacement therapy with oestradiol/dydrogesterone and conjugated equine oestrogen/norgestrel on lipids and symptoms.
    Cieraad D; Conradt C; Jesinger D; Bakowski M
    Arch Gynecol Obstet; 2006 May; 274(2):74-80. PubMed ID: 16491367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Observations with anteovin "step-up" contraceptive tablet in young women.
    Takács G; Hámori M
    Ther Hung; 1986; 34(3):150-4. PubMed ID: 3441877
    [No Abstract]   [Full Text] [Related]  

  • 8. Observations with anteovin in family planning advisory unit.
    Domány Z
    Ther Hung; 1988; 36(1):29-33. PubMed ID: 3388289
    [No Abstract]   [Full Text] [Related]  

  • 9. Observations with anteovin in dermatological disorders.
    Vánkos J
    Ther Hung; 1986; 34(4):204-11. PubMed ID: 2966994
    [No Abstract]   [Full Text] [Related]  

  • 10. Randomized prospective trial of estrogen-replacement therapy in women with a history of breast cancer.
    Vassilopoulou-Sellin R; Theriault RL
    J Natl Cancer Inst Monogr; 1994; (16):153-9. PubMed ID: 7999459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral contraceptives and coronary artery atherosclerosis of cynomolgus monkeys.
    Clarkson TB; Shively CA; Morgan TM; Koritnik DR; Adams MR; Kaplan JR
    Obstet Gynecol; 1990 Feb; 75(2):217-22. PubMed ID: 2300348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormone replacement therapy in young women with surgical primary ovarian insufficiency.
    Sarrel PM; Sullivan SD; Nelson LM
    Fertil Steril; 2016 Dec; 106(7):1580-1587. PubMed ID: 27793381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Examination of the rebound effect of biphasic oral contraceptives.
    Kovács I
    Ther Hung; 1990; 38(3):110-3. PubMed ID: 2284619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular and metabolic effects of medroxyprogesterone acetate versus conjugated equine estrogen after premenopausal hysterectomy with bilateral ovariectomy.
    Kalyan S; Hitchcock CL; Sirrs S; Pudek M; Prior JC
    Pharmacotherapy; 2010 May; 30(5):442-52. PubMed ID: 20411996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The clinico-pharmacological characteristics of anteovin].
    Nikanorova SA; Kononova ES; Korkhov VV; Potin VV; Svechnikova FA; Boĭkova VV
    Farmakol Toksikol; 1991; 54(1):30-1. PubMed ID: 1860494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An unusual case of ovarian resistance syndrome.
    Katz S; Marshall J; Khorram O
    Obstet Gynecol; 2003 May; 101(5 Pt 2):1078-82. PubMed ID: 12738108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response to hormonal treatment of young females with primary or very premature ovarian failure.
    Papagianni V; Deligeoroglou E; Makrakis E; Botsis D; Creatsas G
    Gynecol Endocrinol; 2011 May; 27(5):291-9. PubMed ID: 21381875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic effects of oral contraceptives containing 30 micrograms and 50 micrograms of oestrogen.
    Nash AL; Cornish EJ; Hain R
    Med J Aust; 1979 Sep; 2(6):277-81. PubMed ID: 230411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Puberty menorrhagia due to Bernard Soulier syndrome and its successful treatment by 'Ovral' hormonal tablets.
    Sharma JB; Buckshee K; Sharma S
    Aust N Z J Obstet Gynaecol; 1991 Nov; 31(4):369-70. PubMed ID: 1799356
    [No Abstract]   [Full Text] [Related]  

  • 20. Premenstrual syndrome and oral contraceptives of different character.
    Hetényi G
    Ther Hung; 1988; 36(4):170-3. PubMed ID: 3253960
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.